Development and characterization of a HCMV multiantigen therapeutic vaccine for GBM using the UNITE platform.

e14565Background: Glioblastoma (GBM) is an aggressive form of brain cancer with a median survival of 15 months which has remained unchanged despite technological advances in the standard of care. G...